Freeman Roy Lester

CIK 00017997321 companyATLANTA, GA

SEC Profile

Transactions

Companies

Filings

CIK

0001799732

Recent Transactions

21 trades

Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-02-14+22,640→ 22,640 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21+21,854→ 21,854 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21+3,780→ 3,780 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21+6,667→ 6,667 total
Disposition to Issuer
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21−3,780→ 0 total
Disposition to Issuer
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21−6,667→ 0 total
Disposition to Issuer
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21−1,138→ 0 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21+6,667→ 6,667 total
Disposition to Issuer
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21−30,000→ 0 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21+30,000→ 30,000 total
Disposition to Issuer
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21−6,667→ 0 total
Disposition to Issuer
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21−21,854→ 0 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-21+1,138→ 1,138 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-03+316,647→ 316,647 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-03+172,191→ 172,191 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (Right to Buy)
2025-01-03+344,452→ 344,452 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (right to buy)
2024-07-16+30,000→ 30,000 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (right to buy)
2023-06-30+6,667→ 6,667 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (right to buy)
2022-06-24+40,000→ 40,000 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (right to buy)
2021-06-25+22,677→ 22,677 total
Award
Inhibikase Therapeutics, Inc.$IKT
Stock Option (right to buy)
2020-12-22+6,825→ 6,825 total

Companies

Inhibikase Therapeutics, Inc.
Director
$IKT

Recent Filings

Address

3350 RIVERWOOD PARKWAY SE, SUITE 1900

ATLANTA, GA, 30339

View on SEC.gov